Niklas advises clients on all aspects of European and German competition law – including on M&A projects, cartel and antitrust proceedings, internal investigations.
As a member of the firm's antirust, competition and trade practice group, Niklas covers the entire range of European and German competition law.
Niklas regularly advises clients on cross-border transactions, including all aspects of merger control, foreign direct investment (FDI) screening and the EU Foreign Subsidies Regulation (FSR). He has broad experience representing clients before the European Commission and the German Federal Cartel Office, and often coordinates local filings in other jurisdictions.
Further, Niklas has extensive experience in antitrust investigations and defending clients in fine proceedings.
Niklas' recent practice includes work for clients active in logistics, pharma / life sciences, consumer products, as well as private capital clients.
Niklas speaks German and English.
Niklas' experience includes advising:
- DSV on its acquisition of Schenker, a leading logistics service provider
- Various pharma clients on topics of merger control under EU and German rules
- Novartis on its acquisition of MorphoSys AG, a global biopharmaceutical company developing innovative medicines in oncology
- Fresenius on its divestment of Eugin Group, a global leader in fertility and reproduction services
- EQT on the divestment of Schülke & Mayr, a leading provider of infection prevention and treatment solutions for the healthcare industry
- Beiersdorf on its acquisition of Chantecaille, a leading prestige beauty company
- Hellman & Friedman on the public takeover offer for zooplus, a leading European online pet platform
- Altor Equity Partners and SMS Group on a joint investment in KAEFER Isoliertechnik GmbH & Co. KG, a global industrial services company
Feldmühleplatz 1